| scholarly article | Q13442814 |
| P356 | DOI | 10.1634/STEMCELLS.2006-0833 |
| P698 | PubMed publication ID | 17395771 |
| P50 | author | Dirk Strunk | Q45503167 |
| Katharina Schallmoser | Q50648053 | ||
| Eva Rohde | Q51471409 | ||
| Andreas Reinisch | Q56930266 | ||
| P2093 | author name string | Christian Guelly | |
| Werner Linkesch | |||
| Gerhard Lanzer | |||
| Christina Bartmann | |||
| P433 | issue | 7 | |
| P304 | page(s) | 1746-1752 | |
| P577 | publication date | 2007-03-29 | |
| P1433 | published in | Stem Cells | Q15724411 |
| P1476 | title | Immune cells mimic the morphology of endothelial progenitor colonies in vitro | |
| P478 | volume | 25 |
| Q63916383 | A Potential Role for Exosomal Translationally Controlled Tumor Protein Export in Vascular Remodeling in Pulmonary Arterial Hypertension |
| Q34104821 | Acute lung injury but not sepsis is associated with increased colony formation by peripheral blood mononuclear cells |
| Q36422761 | Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper. |
| Q37231424 | Assessing identity, phenotype, and fate of endothelial progenitor cells |
| Q34630397 | Association of colony-forming units with coronary artery and abdominal aortic calcification |
| Q35611763 | Biological properties of extracellular vesicles and their physiological functions. |
| Q37637396 | Bone marrow cell therapies for endothelial repair and their relevance to kidney disease |
| Q34807168 | Bone marrow characteristics associated with changes in infarct size after STEMI: a biorepository evaluation from the CCTRN TIME trial. |
| Q42055692 | Bone marrow-derived cells do not engraft into skeletal muscle microvasculature but promote angiogenesis after acute injury |
| Q33806247 | Bone marrow-derived vascular modulatory cells in pulmonary arterial hypertension |
| Q83045507 | CD16 antigen is a positive marker of peripheral blood-derived early endothelial progenitor cells |
| Q47378554 | CD34+ cells augment endothelial cell differentiation of CD14+ endothelial progenitor cells in vitro |
| Q28293322 | Circulating and tissue resident endothelial progenitor cells |
| Q41109188 | Circulating endothelial progenitor cells are not affected by acute systemic inflammation |
| Q37163533 | Colony forming unit endothelial cells do not exhibit telomerase alternative splicing variants and activity. |
| Q36055443 | Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. |
| Q28080127 | Developmental origin and lineage plasticity of endogenous cardiac stem cells |
| Q34658637 | E-selectin mediated adhesion and migration of endothelial colony forming cells is enhanced by SDF-1α/CXCR4. |
| Q37434313 | Effects of androgens on endothelial progenitor cells in vitro and in vivo. |
| Q37699573 | Endothelial Progenitor Cells of the Human Placenta and Fetoplacental Circulation: A Potential Link to Fetal, Neonatal, and Long-term Health |
| Q37435004 | Endothelial cell colony forming units derived from malignant breast diseases are resistant to tumor necrosis factor-α-induced apoptosis |
| Q43987732 | Endothelial cells (EC) and endothelial precursor cells (EPC) kinetics in hematological patients undergoing chemotherapy or autologous stem cell transplantation (ASCT). |
| Q37098713 | Endothelial progenitor cell number and colony-forming capacity in overweight and obese adults. |
| Q37679623 | Endothelial progenitor cells and endothelial vesicles - what is the significance for patients with chronic kidney disease? |
| Q36011477 | Endothelial progenitor cells in atherosclerosis |
| Q37776785 | Endothelial progenitor cells: Quo Vadis? |
| Q36084953 | Endothelial progenitor cells: a new player in lupus? |
| Q28303395 | Endothelial progenitor cells: identity defined? |
| Q46643237 | Fat-Derived Stromal Vascular Fraction Cells Enhance the Bone-Forming Capacity of Devitalized Engineered Hypertrophic Cartilage Matrix. |
| Q37311008 | GMP-based CD133(+) cells isolation maintains progenitor angiogenic properties and enhances standardization in cardiovascular cell therapy |
| Q34055122 | Globular domain of adiponectin: promising target molecule for detection of atherosclerotic lesions |
| Q38549001 | Glucose and acute exercise influence factors secreted by circulating angiogenic cells in vitro |
| Q36114568 | Granulocyte colony-stimulating factor (G-CSF) depresses angiogenesis in vivo and in vitro: implications for sourcing cells for vascular regeneration therapy |
| Q37262399 | Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo. |
| Q34796228 | Identification of an effective early signaling signature during neo-vasculogenesis in vivo by ex vivo proteomic profiling |
| Q36998333 | Identification of mouse colony-forming endothelial progenitor cells for postnatal neovascularization: a novel insight highlighted by new mouse colony-forming assay |
| Q84733019 | Insulin resistance and oxidative stress influence colony-forming unit-endothelial cells capacity in obese patients |
| Q42161736 | Interval exercise increases angiogenic cell function in postmenopausal women |
| Q51100722 | Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery |
| Q35882798 | It is all in the blood: the multifaceted contribution of circulating progenitor cells in diabetic complications |
| Q34907048 | Microarray-based characterization of a colony assay used to investigate endothelial progenitor cells and relevance to endothelial function in humans |
| Q21202035 | Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities. |
| Q35625946 | Occurring of In Vitro Functional Vasculogenic Pericytes from Human Circulating Early Endothelial Precursor Cell Culture. |
| Q38444449 | Pro-angiogenic induction of myeloid cells for therapeutic angiogenesis can induce mitogen-activated protein kinase p38-dependent foam cell formation. |
| Q33896772 | Proangiogenic cell colonies grown in vitro from human peripheral blood mononuclear cells |
| Q34686863 | Prolongation of cardiac allograft survival by a novel population of autologous CD117+ bone marrow-derived progenitor cells |
| Q38600563 | RESPONSE TO LETTER TO THE EDITOR - "Critical assessment of putative endothelial progenitor phenotypes" by Gian Paolo Fadini, et al |
| Q37200278 | Release of proinflammatory mediators and expression of proinflammatory adhesion molecules by endothelial progenitor cells |
| Q40821352 | Replicative senescence-associated gene expression changes in mesenchymal stromal cells are similar under different culture conditions |
| Q34625321 | Resident vascular progenitor cells--diverse origins, phenotype, and function |
| Q37070827 | Resident vascular progenitor cells: an emerging role for non-terminally differentiated vessel-resident cells in vascular biology |
| Q37202001 | Revascularization of ischemic limbs after transplantation of human bone marrow cells with high aldehyde dehydrogenase activity. |
| Q28078600 | Stem/progenitor cells and obstructive sleep apnea syndrome - new insights for clinical applications |
| Q36632989 | Systematic assessment in an animal model of the angiogenic potential of different human cell sources for therapeutic revascularization |
| Q36447411 | Telomeres, atherosclerosis, and the hemothelium: the longer view |
| Q37374031 | The definition of EPCs and other bone marrow cells contributing to neoangiogenesis and tumor growth: is there common ground for understanding the roles of numerous marrow-derived cells in the neoangiogenic process? |
| Q30497355 | The detrimental effects of IFN-α on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction |
| Q37276042 | The promise of cell-based therapies for diabetic complications: challenges and solutions |
| Q38035076 | Therapeutic revascularisation of ischaemic tissue: the opportunities and challenges for therapy using vascular stem/progenitor cells |
Search more.